{"nct_id":"NCT06946797","title":"A Study to Evaluate Two Dosing Regimens of Subcutaneous Nivolumab in Combination With Intravenous Ipilimumab and Chemotherapy in Participants With Previously Untreated Metastatic or Recurrent Non-Small Cell Lung Cancer (NSCLC)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-09-15","start_date_type":"ESTIMATED","primary_completion_date":"2027-02-05","primary_completion_date_type":"ESTIMATED","completion_date":"2028-10-25","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BMY"]}